{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/652558c78b631000124f5568?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Under the Skin","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/652558c78b631000124f5568/1715958663368-8fac55082d92a8c4e1e9ee96e9ea50a7.jpeg?height=200","description":"<p>This podcast is aimed at healthcare professionals, produced and funded by UCB.</p><p><br></p><p>‘Under the Skin’, UCB’s&nbsp;latest podcast series, is targeted at healthcare professionals looking to learn more about hidradenitis suppurativa (HS), a debilitating, chronic inflammatory skin disease.(1)</p><p><br></p><p>Hosted by Dr Barry McGrath (HS patient advocate and co-founder of patient association HS Ireland), each episode invites a new expert guest to share their knowledge of treating HS and to discuss one of the many facets of the complex patient journey.</p><p><br></p><p>As a pharmaceutical company, UCB adheres to the ABPI and IPHA codes applicable to the UK and Ireland and European Federation of Pharmaceutical Industries and Associations (EFPIA) Code of Practice.</p><p><br></p><p>Reference:</p><ol><li>Alikhan A, et al. J Am Acad Dermatol. 2019;81(1):91–101;</li></ol><p><br></p><p><a href=\"https://www.ucb.com/contact\" rel=\"noopener noreferrer\" target=\"_blank\">https://www.ucb.com/contact</a></p>","author_name":"UCB Biopharma"}